Non-interventional and cross-sectional study to evaluate the functional impact of newly diagnosed relapsing remitting multiple sclerosis from the perspective of patients (MS-ONSET Study)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ROCHE FARMA, SA
- Execution start: 23/07/2020
- End of execution: 30/09/2021
- PI: FRANCISCO JAVIER BARRERO HERNANDEZ